During tumorigenesis, the shift from oxidative phosphorylation to glycolysis in ATP production accounts for the dramatic change in the cellular metabolism and represents one of the major steps leading to tumour formation. The so-called Warburg effect is currently considered something more than a mere modification in the cellular metabolism. The paradox that during cancer cell proliferation the increase in energy need is supplied by glycolysis can be only explained by taking into account the many roles that intermediates of glycolysis or TCA cycle play in cellular physiology, besides energy production. Recent studies have shown that metabolic intermediates induce changes in chromatin structure or drive neo-angiogenesis. In this review, we present some of the latest findings in the study of cancer metabolism with particular attention to how tumour metabolism and its microenvironment can favour tumour growth and aggressiveness, by hijacking and dampening the anti-tumoral immune response.

Corrado, M., Scorrano, L., & Campello, S. (2016). Changing perspective on oncometabolites: From metabolic signature of cancer to tumorigenic and immunosuppressive agents. ONCOTARGET, 7(29), 46692-46706 [10.18632/oncotarget.8727].

Changing perspective on oncometabolites: From metabolic signature of cancer to tumorigenic and immunosuppressive agents

Campello S.
2016

Abstract

During tumorigenesis, the shift from oxidative phosphorylation to glycolysis in ATP production accounts for the dramatic change in the cellular metabolism and represents one of the major steps leading to tumour formation. The so-called Warburg effect is currently considered something more than a mere modification in the cellular metabolism. The paradox that during cancer cell proliferation the increase in energy need is supplied by glycolysis can be only explained by taking into account the many roles that intermediates of glycolysis or TCA cycle play in cellular physiology, besides energy production. Recent studies have shown that metabolic intermediates induce changes in chromatin structure or drive neo-angiogenesis. In this review, we present some of the latest findings in the study of cancer metabolism with particular attention to how tumour metabolism and its microenvironment can favour tumour growth and aggressiveness, by hijacking and dampening the anti-tumoral immune response.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/13
English
Con Impact Factor ISI
cancer; immune response; lymphocytes; metabolism
Corrado, M., Scorrano, L., & Campello, S. (2016). Changing perspective on oncometabolites: From metabolic signature of cancer to tumorigenic and immunosuppressive agents. ONCOTARGET, 7(29), 46692-46706 [10.18632/oncotarget.8727].
Corrado, M; Scorrano, L; Campello, S
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
23 2016 Corrado Oncotarget rev.pdf

accesso aperto

Licenza: Copyright dell'editore
Dimensione 1.28 MB
Formato Adobe PDF
1.28 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/191215
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 20
social impact